Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis
View ORCID ProfileAaron Leong, View ORCID ProfileJoanne Cole, Laura N. Brenner, View ORCID ProfileJames B. Meigs, View ORCID ProfileJose C. Florez, View ORCID ProfileJosep M. Mercader
doi: https://doi.org/10.1101/2020.08.26.20182709
Aaron Leong
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
2Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
Joanne Cole
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
5Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children’s Hospital, Boston, MA, USA
Laura N. Brenner
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
6Division on Pulmonary and Critical Care, Massachusetts General Hospital, Boston MA
James B. Meigs
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
2Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Jose C. Florez
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
Josep M. Mercader
3Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Posted September 01, 2020.
Cardiometabolic Risk Factors for COVID-19 Susceptibility and Severity: A Mendelian Randomization Analysis
Aaron Leong, Joanne Cole, Laura N. Brenner, James B. Meigs, Jose C. Florez, Josep M. Mercader
medRxiv 2020.08.26.20182709; doi: https://doi.org/10.1101/2020.08.26.20182709
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2974)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12833)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4630)
- Geriatric Medicine (425)
- Health Economics (733)
- Health Informatics (2947)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (477)
- Neurology (4425)
- Nursing (238)
- Nutrition (653)
- Oncology (2300)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (504)
- Public and Global Health (7016)
- Radiology and Imaging (1552)
- Respiratory Medicine (923)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (492)
- Toxicology (60)
- Transplantation (213)
- Urology (185)